Table 5.
Treatment outcomes of radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma
| Author | Year | n | Dose (Gy) | Combined treatment | Response rate | MST (months) |
|---|---|---|---|---|---|---|
| Tazawa et al.( 23 ) | 2001 | 24 | 50 | TACE | 50% | 3.8–9.7 |
| Ishikura et al.( 24 ) | 2002 | 20 | 50 | TACE | 50% | 5.3 |
| Yamada et al.( 25 ) | 2003 | 19 | 46–60 | TACE | 57.9% | 7.0 |
| Kim et al.( 14 ) | 2005 | 59 | 30–54 | Unknown | 45.8% | 5.3–10.7 |
| Zeng et al.( 13 ) | 2005 | 44 | 36–50 | TACE ± resection | 45.5% | 8.0 |
| Lin et al.( 16 ) | 2006 | 43 | 45 | None | 75% | 6.0–6.7 |
| Toya et al.( 15 ) | 2007 | 38 | 23–59 | None | 44.7% | 9.6 |
| This study† | 2007 | 94 | 30–60 | TACE ± resection | 41.3% | 9.7 |
MST, median survival time; TACE, transcatheter arterial chemoembolization.
†
This study overlaps and contains the 44 patients treated with EBRT shown above for reference 13.